György Várady - Concepedia

Author

György Várady

Institute of Molecular Life Sciences ORCID

Also Known As

Dokholyan, Nikolay V., G Várady, G. Varady, Gyorgy Varady, György Várady, György Várady, Várady, György

100

Publications

2.1K

Citations

H-Index

101

Concepts

All Affiliations

Institute of Molecular Life Sciences HUN-REN Research Centre for Natural Sciences Hungarian Academy of Sciences Semmelweis University Hungarian National Blood Transfusion Service

About

György Várady is an author at Institute of Molecular Life Sciences specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	23	713
2	Natural Sciences	7	7	196
3	Health Sciences	4	4	122
4	Engineering	3	3	111
5	Allergy	1	1	45

György Várady

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter Csilla Özvegy‐Laczka, Tamás Hegedűs, György Várady, Molecular Pharmacology	2004	339
Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib) N. Barry Elkind, Zsófia Szentpétery, Ágota Apáti, Cancer Research	2005	224
Function-dependent Conformational Changes of the ABCG2 Multidrug Transporter Modify Its Interaction with a Monoclonal Antibody on the Cell Surface Csilla Özvegy‐Laczka, György Várady, Gabriella Köblös, Journal of Biological Chemistry	2004	92
High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells Ágota Apáti, Tamás I. Orbán, Nóra Varga, Biochimica et Biophysica Acta (BBA) - Biomembranes Induced Pluripotent Stem CellDevelopmental BiologySignal TransductionMedicineStem Cell Research	2008	86
Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance Csilla Hegedüs, Krisztina Truta-Feles, Géza Antalffy, Biochemical Pharmacology Health SciencesCancer Drug ResistanceMedicineCancer GrowthEgfr Inhibitors	2012	71
Applying a “Double-Feature” Promoter to Identify Cardiomyocytes Differentiated from Human Embryonic Stem Cells Following Transposon-Based Gene Delivery Tamás I. Orbán, Ágota Apáti, Andrea H. Németh, Stem Cells	2009	59
Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of Organic Anion-Transporting Polypeptides, OATP1B1/1B3 and 2B1 Izabel Patik, Virág Székely, Orsolya Német, Scientific Reports	2018	55
Reliable transgene-independent method for determining Sleeping Beauty transposon copy numbers Orsolya Kolacsek, Virág Krízsik, Anita Schamberger, Mobile DNA	2011	54
Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters Ágnes Telbisz, Csilla Temesszentandrási‐Ambrus, Orsolya Mózner, Pharmaceutics Multispecific AbcImmunologyAntiviral DrugDrug ResistanceRelevant Transporter Interactions	2021	47
Expression Levels of the ABCG2 Multidrug Transporter in Human Erythrocytes Correspond to Pharmacologically Relevant Genetic Variations Ildikó Kasza, György Várady, Hajnalka Andrikovics, PLoS ONE EngineeringUric Acid MetabolismImmunologyBlood CellPathology	2012	46

Page 1